# Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.

> **NCT05595681** · PHASE1 · TERMINATED · sponsor: **Cell to Cure ApS** · enrollment: 21 (actual)

## Conditions studied

- Diabetic Foot Ulcer
- Mesenchymal Stromal Cells

## Interventions

- **DRUG:** Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)

## Key facts

- **NCT ID:** NCT05595681
- **Lead sponsor:** Cell to Cure ApS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-12-15
- **Primary completion:** 2025-11-28
- **Final completion:** 2025-11-28
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Difficulties in enrolling trial subjects within in- and exclusion criteria, despite the trial period having been extended several times.
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05595681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05595681, "Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05595681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*